The Phosphorylated ATM Immunofluorescence Assay: A High-performance Radiosensitivity Assay to Predict Postradiation Therapy Overreactions.

@article{Vogin2018ThePA,
  title={The Phosphorylated ATM Immunofluorescence Assay: A High-performance Radiosensitivity Assay to Predict Postradiation Therapy Overreactions.},
  author={Guillaume Vogin and Thierry Bastogne and Larry Bodgi and Julien Gillet-Daubin and Aur{\'e}lien Canet and Sandrine Pereira and Nicolas Foray},
  journal={International journal of radiation oncology, biology, physics},
  year={2018},
  volume={101 3},
  pages={
          690-693
        }
}
PURPOSE The ability to identify, before treatment, those patients who will overreact to radiation therapy would have sound positive clinical implications. By focusing on DNA double-strand breaks recognition and repair proteins after irradiation, we recently demonstrated that the maximal number of phosphorylated ATM (pATM) nuclear foci in the first hour… CONTINUE READING